The FDA has issued a new diabetes drug warning concerning a class of drugs called SGLT2 inhibitors that are designed to treat type 2 diabetes.  The warning states that the agency has received reports of ketoacidosis, a condition involving dangerously high levels of acid in... Read More

Another Januvia cancer lawsuit has been added to the growing ledger against drug manufacturing titan Merck & Co. in federal and state courts. It alleges that the pancreatic cancer death of Bettye Jean Alexander of Georgia was due to Merck’s relentless pursuit of market share... Read More

Manufactured by pharmaceutical giant Merck and Co., Januvia is a top-selling diabetes medication used by millions of Americans. The drug is type of DPP-4 inhibitor and one of the first of its kind to be cleared by the FDA nearly eight years ago. Since its commercial... Read More

AstraZeneca, the global biopharmaceutical company, disclosed in their second quarter financial report last week that while it has resolved 84 Byetta lawsuits pending in California, it still faces over 400 lawsuits in various state and federal courts nationwide. The Byetta lawsuits allege that former users... Read More

Yet another Januvia side effects lawsuit has been joined to Multi District Litigation (MDL) now proceeding against Merck and other makers of a controversial new class of incretin mimetics drugs allegedly linked to pancreatic cancer. The MDL, which was consolidated last year in the Southern District of... Read More

As of 2013, over 26 million adults and children living in the United States were suffering from diabetes. As such, it is no wonder that the number of diabetes drugs hitting the market seems to increase each year – as well as the number of... Read More

A Pennsylvania couple has filed a Januvia pancreatitis lawsuit against Amylin Pharmaceuticals, et al. alleging that the defendants’ medication directly resulted in the development of acute pancreatitis. Richard and Claire Russo filed the claim on February 18, 2014 in the Superior Court of Los Angeles.... Read More

The diabetes drugs Byetta, Januvia, Janumet and Victoza – all types of incretin mimetics – have been tied to an increased risk of thyroid and pancreatic cancer. Last year, federal multidistrict litigation was established to better handle the escalating litigation involving alleged incretin mimetic side... Read More